BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

472 related articles for article (PubMed ID: 7927779)

  • 1. Vaccination with Brucella abortus rough mutant RB51 protects BALB/c mice against virulent strains of Brucella abortus, Brucella melitensis, and Brucella ovis.
    Jiménez de Bagüés MP; Elzer PH; Jones SM; Blasco JM; Enright FM; Schurig GG; Winter AJ
    Infect Immun; 1994 Nov; 62(11):4990-6. PubMed ID: 7927779
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protection of BALB/c mice against homologous and heterologous species of Brucella by rough strain vaccines derived from Brucella melitensis and Brucella suis biovar 4.
    Winter AJ; Schurig GG; Boyle SM; Sriranganathan N; Bevins JS; Enright FM; Elzer PH; Kopec JD
    Am J Vet Res; 1996 May; 57(5):677-83. PubMed ID: 8723881
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protective role of antibodies induced by Brucella melitensis B115 against B. melitensis and Brucella abortus infections in mice.
    Adone R; Francia M; Pistoia C; Petrucci P; Pesciaroli M; Pasquali P
    Vaccine; 2012 Jun; 30(27):3992-5. PubMed ID: 22521283
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhanced efficacy of recombinant Brucella abortus RB51 vaccines against B. melitensis infection in mice.
    Vemulapalli R; Contreras A; Sanakkayala N; Sriranganathan N; Boyle SM; Schurig GG
    Vet Microbiol; 2004 Sep; 102(3-4):237-45. PubMed ID: 15327798
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Booster vaccination with safe, modified, live-attenuated mutants of Brucella abortus strain RB51 vaccine confers protective immunity against virulent strains of B. abortus and Brucella canis in BALB/c mice.
    Truong QL; Cho Y; Kim K; Park BK; Hahn TW
    Microbiology (Reading); 2015 Nov; 161(11):2137-48. PubMed ID: 26341622
    [TBL] [Abstract][Full Text] [Related]  

  • 6. B. melitensis rough strain B115 is protective against heterologous Brucella spp. infections.
    Adone R; Francia M; Pistoia C; Pesciaroli M; Pasquali P
    Vaccine; 2011 Mar; 29(14):2523-9. PubMed ID: 21300102
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protective immunity to Brucella ovis in BALB/c mice following recovery from primary infection or immunization with subcellular vaccines.
    Jiménez de Bagüés MP; Elzer PH; Blasco JM; Marín CM; Gamazo C; Winter AJ
    Infect Immun; 1994 Feb; 62(2):632-8. PubMed ID: 8300219
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protective properties of rifampin-resistant rough mutants of Brucella melitensis.
    Adone R; Ciuchini F; Marianelli C; Tarantino M; Pistoia C; Marcon G; Petrucci P; Francia M; Riccardi G; Pasquali P
    Infect Immun; 2005 Jul; 73(7):4198-204. PubMed ID: 15972510
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overexpression of wbkF gene in Brucella abortus RB51WboA leads to increased O-polysaccharide expression and enhanced vaccine efficacy against B. abortus 2308, B. melitensis 16M, and B. suis 1330 in a murine brucellosis model.
    Dabral N; Burcham GN; Jain-Gupta N; Sriranganathan N; Vemulapalli R
    PLoS One; 2019; 14(3):e0213587. PubMed ID: 30856219
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Brucella abortus RB51 and hot saline extract from Brucella ovis as antigens in a complement fixation test used To detect sheep vaccinated with Brucella abortus RB51.
    Adone R; Ciuchini F
    Clin Diagn Lab Immunol; 2001 Jan; 8(1):119-22. PubMed ID: 11139204
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of the efficacy of Brucella abortus strain RB51 and Brucella melitensis Rev. 1 live vaccines against experimental infection with Brucella melitensis in pregnant ewes.
    el Idrissi AH; Benkirane A; el Maadoudi M; Bouslikhane M; Berrada J; Zerouali A
    Rev Sci Tech; 2001 Dec; 20(3):741-7. PubMed ID: 11732416
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antigenic, immunologic and genetic characterization of rough strains B. abortus RB51, B. melitensis B115 and B. melitensis B18.
    Adone R; Muscillo M; La Rosa G; Francia M; Tarantino M
    PLoS One; 2011; 6(10):e24073. PubMed ID: 22065984
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The recombinant Omp31 from Brucella melitensis alone or associated with rough lipopolysaccharide induces protection against Brucella ovis infection in BALB/c mice.
    Estein SM; Cassataro J; Vizcaíno N; Zygmunt MS; Cloeckaert A; Bowden RA
    Microbes Infect; 2003 Feb; 5(2):85-93. PubMed ID: 12650766
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison between immune responses and resistance induced in BALB/c mice vaccinated with RB51 and Rev. 1 vaccines and challenged with Brucella melitensis bv. 3.
    Hamdy ME; El-Gibaly SM; Montasser AM
    Vet Microbiol; 2002 Aug; 88(1):85-94. PubMed ID: 12119140
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oral immunization of mice with gamma-irradiated Brucella neotomae induces protection against intraperitoneal and intranasal challenge with virulent B. abortus 2308.
    Dabral N; Martha-Moreno-Lafont ; Sriranganathan N; Vemulapalli R
    PLoS One; 2014; 9(9):e107180. PubMed ID: 25225910
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo differences in the virulence, pathogenicity, and induced protective immunity of wboA mutants from genetically different parent Brucella spp.
    Wang Z; Niu J; Wang S; Lv Y; Wu Q
    Clin Vaccine Immunol; 2013 Feb; 20(2):174-80. PubMed ID: 23239800
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Brucella abortus RB51 vaccine does not confer protection against Brucella ovis in rams.
    Jiménez de Bagüés MP; Barberán M; Marín CM; Blasco JM
    Vaccine; 1995 Feb; 13(3):301-4. PubMed ID: 7631517
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Brucella abortus RB51 induces protection in mice orally infected with the virulent strain B. abortus 2308.
    Pasquali P; Rosanna A; Pistoia C; Petrucci P; Ciuchini F
    Infect Immun; 2003 May; 71(5):2326-30. PubMed ID: 12704101
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Complementation of Brucella abortus RB51 with a functional wboA gene results in O-antigen synthesis and enhanced vaccine efficacy but no change in rough phenotype and attenuation.
    Vemulapalli R; He Y; Buccolo LS; Boyle SM; Sriranganathan N; Schurig GG
    Infect Immun; 2000 Jul; 68(7):3927-32. PubMed ID: 10858205
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of Brucella melitensis B115 as rough-phenotype vaccine against B. melitensis and B. ovis infections.
    Adone R; Francia M; Ciuchini F
    Vaccine; 2008 Sep; 26(38):4913-7. PubMed ID: 18675869
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.